Longitudinal modified treatment policies (LMTP) have been recently developed as a novel method to define and estimate causal parameters that depend on the natural value of treatment. LMTPs represent an important advancement in causal inference for longitudinal studies as they allow the non-parametric definition and estimation of the joint effect of multiple categorical, numerical, or continuous exposures measured at several time points. We extend the LMTP methodology to problems in which the outcome is a time-to-event variable subject to right-censoring and competing risks. We present identification results and non-parametric locally efficient estimators that use flexible data-adaptive regression techniques to alleviate model misspecification bias, while retaining important asymptotic properties such as $\sqrt{n}$-consistency. We present an application to the estimation of the effect of the time-to-intubation on acute kidney injury amongst COVID-19 hospitalized patients, where death by other causes is taken to be the competing event.
翻译:最近制定了经纵向修改的治疗政策(LMTP),作为界定和估计取决于治疗的自然价值的因果参数的新方法。LMTP代表了纵向研究在因果推断方面的一个重要进步,因为可以对在几个时间点测量的多直线、数字或连续接触的共同影响作出非参数定义和估计。我们将LMTP方法扩大到结果为时间到时间的变数,并受到权利检查和相互竞争风险的问题。我们介绍了使用灵活的数据适应回归技术来减轻模型偏差的当地有效测算员的结果和非参数,同时保留了重要的非参数特性,如$\sqrt{n}美元-一致性。我们介绍了对CVID-19住院病人急性肾损伤时间到干预的影响的估计,其中将其他原因引起的死亡视为相互竞争的事件。